Pure Global

STANBIO Bilirubin Liquicolor Total and Direct - Indonesia BPOM Medical Device Registration

STANBIO Bilirubin Liquicolor Total and Direct is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101213039. The device is manufactured by STANBIO LABORATORY INC. from United States, and is classified as Risk Class Kelas Resiko : C. The authorized representative in Indonesia is PT. MITRA BAHAGIA CITRA MEDIKA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : C
STANBIO Bilirubin Liquicolor Total and Direct
Analysis ID: AKL 20101213039

Risk Classification

Kelas Resiko : C

Product Class

Kelas : 2

Country of Origin

United States

Authorized Representative

PT. MITRA BAHAGIA CITRA MEDIKA

AR Address

Jl. Raya Kalirungkut 27 Blok C-63

Registration Date

Jan 24, 2023

Expiry Date

Dec 31, 2025

Product Type

Clinical Chemistry Test System

Bilirubin (total or direct) test system

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing